课题基金 / 基金详情

Integrated Epithelial and Mucosal Biology

Integrated Epithelial and Mucosal Biology
综合上皮和粘膜生物学
批准号:
8971189
负责人:
WAYNE I LENCER
金额:
$138.43万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-09-01 至 2020-11-30

项目摘要

项目成果

WAYNE I LENCER的其他基金

相似基金

相关文献

中文摘要
翻译

英文摘要
 DESCRIPTION OF OVERALL CENTER (provided by applicant): The Harvard Digestive Disease Center (HDDC) is a community of 61 independent investigators with over $34M (28% NIDDK) annual research funding and 21 Associate Members, all conducting research directly related to digestive diseases. HDDC members' research addresses the fundamental mechanisms that underlie normal digestive tract function and the pathogenesis of digestive disease, focusing on 4 Themes: Epithelial Cell, Developmental, and Stem Cell Biology; Innate and Adaptive Mucosal Immunology; Gut Infections and Microbiome; and Hepatic Cell Physiology and Metabolism. These research areas address the basis for intestinal and inflammatory bowel diseases; gut infections; effects of the gut microbiome on intestinal and systemic physiology and metabolism; and regenerative medicine of the intestine and liver. Members' resources and technical capabilities are amplified through services, equipment and training in 3 Biomedical Cores that provide (B) high-resolution microscopy & histopathology, (C) epithelial cell culture & mucosal cell analysis, and (D) gnotobiotic mice, microbiological and metabolic analyses. The HDDC Clinical Component supports clinical and translational GI research through HDDC-subsidized biostatistical and bio-repository services. The Center fosters scientific collaborations through an Enrichment Program organized by Themes, including an annual symposium, a biennial regional conference "Frontiers in Mucosal Immunology", seminars, and workshops focused on young investigators. The HDDC also promotes training of young scientists through a competitive Pilot- Feasibility Grant Program that has supported 45 trainees in the past 8 years, with all but one still active in digestive diseases-related research. Center Directors Wayne Lencer (PI) and Associate Director Richard Blumberg (Co-PI) are Division Chiefs of Pediatric and Adult GI at two major Harvard teaching hospitals, and leaders of NIH-funded training programs in Gastroenterology. They are assisted by an Executive Committee that includes all Core Directors and Theme Leaders, and guided by an External Advisory Board of leaders in GI-related research. The HDDC's overarching mission is to foster and expand basic and translational science in digestive diseases by connecting people, creating opportunity, and extending resources.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of action for the IBD-risk gene INAVA: an epithelial guard receptor for inflammation and integrity of the intestinal barrier
  • 批准号:
    10214604
  • 项目类别:
  • 资助金额:
    $51.69万
  • 财政年份:
    2020
  • 负责人:
    WAYNE I LENCER
  • 依托单位:
Mechanisms of action for the IBD-risk gene INAVA: an epithelial guard receptor for inflammation and integrity of the intestinal barrier
  • 批准号:
    10626015
  • 项目类别:
  • 资助金额:
    $49.24万
  • 财政年份:
    2020
  • 负责人:
    WAYNE I LENCER
  • 依托单位:
Mechanisms of action for the IBD-risk gene INAVA: an epithelial guard receptor for inflammation and integrity of the intestinal barrier
  • 批准号:
    10405643
  • 项目类别:
  • 资助金额:
    $49.24万
  • 财政年份:
    2020
  • 负责人:
    WAYNE I LENCER
  • 依托单位:
Intestinal Disease-enterocyte toxin interaction
  • 批准号:
    9263933
  • 项目类别:
  • 资助金额:
    $71.69万
  • 财政年份:
    2016
  • 负责人:
    WAYNE I LENCER
  • 依托单位:
海外基金